Cargando…
A Personalized and Learning Approach for Identifying Drugs with Adverse Events
PURPOSE: Adverse drug events (ADEs) are associated with high health and financial costs and have increased as more elderly patients treated with multiple medications emerge in an aging society. It has thus become challenging for physicians to identify drugs causing adverse events. This study propose...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653490/ https://www.ncbi.nlm.nih.gov/pubmed/29047249 http://dx.doi.org/10.3349/ymj.2017.58.6.1229 |
_version_ | 1783273228828934144 |
---|---|
author | Shin, Sug Kyun Hur, Ho Cheon, Eun Kyung Oh, Ock Hee Lee, Jeong Seon Ko, Woo Jin Kim, Beom Seok Kwon, YoungOk |
author_facet | Shin, Sug Kyun Hur, Ho Cheon, Eun Kyung Oh, Ock Hee Lee, Jeong Seon Ko, Woo Jin Kim, Beom Seok Kwon, YoungOk |
author_sort | Shin, Sug Kyun |
collection | PubMed |
description | PURPOSE: Adverse drug events (ADEs) are associated with high health and financial costs and have increased as more elderly patients treated with multiple medications emerge in an aging society. It has thus become challenging for physicians to identify drugs causing adverse events. This study proposes a novel approach that can improve clinical decision making with recommendations on ADE causative drugs based on patient information, drug information, and previous ADE cases. MATERIALS AND METHODS: We introduce a personalized and learning approach for detecting drugs with a specific adverse event, where recommendations tailored to each patient are generated using data mining techniques. Recommendations could be improved by learning the associations of patients and ADEs as more ADE cases are accumulated through iterations. After consulting the system-generated recommendations, a physician can alter prescriptions accordingly and report feedback, enabling the system to evolve with actual causal relationships. RESULTS: A prototype system is developed using ADE cases reported over 1.5 years and recommendations obtained from decision tree analysis are validated by physicians. Two representative cases demonstrate that the personalized recommendations could contribute to more prompt and accurate responses to ADEs. CONCLUSION: The current system where the information of individual drugs exists but is not organized in such a way that facilitates the extraction of relevant information together can be complemented with the proposed approach to enhance the treatment of patients with ADEs. Our illustrative results show the promise of the proposed system and further studies are expected to validate its performance with quantitative measures. |
format | Online Article Text |
id | pubmed-5653490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Yonsei University College of Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-56534902017-11-01 A Personalized and Learning Approach for Identifying Drugs with Adverse Events Shin, Sug Kyun Hur, Ho Cheon, Eun Kyung Oh, Ock Hee Lee, Jeong Seon Ko, Woo Jin Kim, Beom Seok Kwon, YoungOk Yonsei Med J Original Article PURPOSE: Adverse drug events (ADEs) are associated with high health and financial costs and have increased as more elderly patients treated with multiple medications emerge in an aging society. It has thus become challenging for physicians to identify drugs causing adverse events. This study proposes a novel approach that can improve clinical decision making with recommendations on ADE causative drugs based on patient information, drug information, and previous ADE cases. MATERIALS AND METHODS: We introduce a personalized and learning approach for detecting drugs with a specific adverse event, where recommendations tailored to each patient are generated using data mining techniques. Recommendations could be improved by learning the associations of patients and ADEs as more ADE cases are accumulated through iterations. After consulting the system-generated recommendations, a physician can alter prescriptions accordingly and report feedback, enabling the system to evolve with actual causal relationships. RESULTS: A prototype system is developed using ADE cases reported over 1.5 years and recommendations obtained from decision tree analysis are validated by physicians. Two representative cases demonstrate that the personalized recommendations could contribute to more prompt and accurate responses to ADEs. CONCLUSION: The current system where the information of individual drugs exists but is not organized in such a way that facilitates the extraction of relevant information together can be complemented with the proposed approach to enhance the treatment of patients with ADEs. Our illustrative results show the promise of the proposed system and further studies are expected to validate its performance with quantitative measures. Yonsei University College of Medicine 2017-11-01 2017-09-28 /pmc/articles/PMC5653490/ /pubmed/29047249 http://dx.doi.org/10.3349/ymj.2017.58.6.1229 Text en © Copyright: Yonsei University College of Medicine 2017 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Shin, Sug Kyun Hur, Ho Cheon, Eun Kyung Oh, Ock Hee Lee, Jeong Seon Ko, Woo Jin Kim, Beom Seok Kwon, YoungOk A Personalized and Learning Approach for Identifying Drugs with Adverse Events |
title | A Personalized and Learning Approach for Identifying Drugs with Adverse Events |
title_full | A Personalized and Learning Approach for Identifying Drugs with Adverse Events |
title_fullStr | A Personalized and Learning Approach for Identifying Drugs with Adverse Events |
title_full_unstemmed | A Personalized and Learning Approach for Identifying Drugs with Adverse Events |
title_short | A Personalized and Learning Approach for Identifying Drugs with Adverse Events |
title_sort | personalized and learning approach for identifying drugs with adverse events |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653490/ https://www.ncbi.nlm.nih.gov/pubmed/29047249 http://dx.doi.org/10.3349/ymj.2017.58.6.1229 |
work_keys_str_mv | AT shinsugkyun apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT hurho apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT cheoneunkyung apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT ohockhee apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT leejeongseon apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT kowoojin apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT kimbeomseok apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT kwonyoungok apersonalizedandlearningapproachforidentifyingdrugswithadverseevents AT shinsugkyun personalizedandlearningapproachforidentifyingdrugswithadverseevents AT hurho personalizedandlearningapproachforidentifyingdrugswithadverseevents AT cheoneunkyung personalizedandlearningapproachforidentifyingdrugswithadverseevents AT ohockhee personalizedandlearningapproachforidentifyingdrugswithadverseevents AT leejeongseon personalizedandlearningapproachforidentifyingdrugswithadverseevents AT kowoojin personalizedandlearningapproachforidentifyingdrugswithadverseevents AT kimbeomseok personalizedandlearningapproachforidentifyingdrugswithadverseevents AT kwonyoungok personalizedandlearningapproachforidentifyingdrugswithadverseevents |